Sekar Kathiresan, M.D.
Incoming Chief Executive Officer and Co-Founder
Sekar Kathiresan is a preventive cardiologist who has made groundbreaking discoveries of cardioprotective genetic mutations, which confer resistance to cardiovascular disease. He is director of the Massachusetts General Hospital (MGH) Center for Genomic Medicine and the Ofer and Shelly Nemirovsky MGH Research Scholar, director of the Cardiovascular Disease Initiative at the Broad Institute, and professor of medicine at Harvard Medical School. Dr. Kathiresan’s research laboratory focuses on understanding the inherited basis for blood lipids and myocardial infarction and using these insights to improve preventive cardiac care. For his research contributions, he has been honored with a Distinguished Scientist Award from the American Heart Association and the 2018 Curt Stern Award from the American Society of Human Genetics. In tandem with his research, his clinical focus is the primary prevention of myocardial infarction in individuals with a family history of heart attack. He graduated summa cum laude with a B.A. in history from the University of Pennsylvania and received his M.D. from Harvard Medical School. Dr. Kathiresan completed his clinical training in internal medicine and cardiology at MGH and his postdoctoral research training in human genetics at the Framingham Heart Study and the Broad Institute.